RNWL
INTERNATIONAL REGISTRATION RENEWED
10/02/2025
Back to search
Official data from USPTO
CONTERA PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
10/03/2025
Trademark type
Combined
Nice classes
5, 35
Filing date
09/04/2015
Registration date
01/03/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/14/2023
Last transaction
10/03/2025
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
3
Owner type
24
Owner location
DK
Examiner
WEIGLE,KATHERINE CONNOLLY
Law office
L10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the wording "CONTERA PHARMA" with straight vertical lines appearing below the wording, all in blue.
Holders and representatives
Holders
Contera Pharma A/S
C. A. (pessoa física)
Representatives
Julie A. Greenberg Fishman Stewart PLLC
Technical classification
Nice Classes
Class 5Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Antibiotics; antiviralschemical preparations for pharmaceutical purposesfor treatmentprevention or alleviation of diseases of the central nervous systemneurological disorderspsychiatric disordersmovement disordersextrapyramidal disordershyperkinetic movement disordershypokinetic movement disordersparkinsonismParkinson's Diseasedyskinesias and complications arising from same; drugs for medical purposespharmaceutical preparations for the treatmentprevention or alleviation of diseases of the central nervous systemneurological disorderspsychiatric disordersmovement disordersextrapyramidal disordershyperkinetic movement disordershypokinetic movement disordersparkinsonismParkinson's Diseasedyskinesias and complications arising from same; medicines for human purposes for treatmentprevention or alleviation of diseases of the central nervous systemneurological disorderspsychiatric disordersmovement disordersextrapyramidal disordershyperkinetic movement disordershypokinetic movement disordersparkinsonismParkinson's Diseasedyskinesias and complications arising from same; pharmaceutical preparations for the treatmentprevention or alleviation of diseases of the central nervous systemneurological disorderspsychiatric disordersmovement disordersextrapyramidal disordershyperkinetic movement disordershypokinetic movement disordersparkinsonismParkinson's Diseasedyskinesias and complications arising from same; vitamin preparations; health supplements for medical usehealth food supplementsdietary and nutritional supplementsherbal supplements
Class 35
Pharmaceutical sales promotion for others; business information on pharmaceuticals; business management assistance on pharmaceuticals; market search; market study; advertising services; arranging of pharmaceutical saleprocuring of contracts for the purchase and sale of pharmaceuticals; export-import agency; sales agency business of health supplementary foodmarketing services for health supplementary foodspromotional marketing and representation services for sales to the public sector of health supplementary foodindependent sales representatives in the field of health supplementary food; retail store services in the field of cosmetics; retail store services in the field of dentifrices; retail store services in the field of toothbrushes
Publications
History of USPTO decisions and trademark events.
43 publications found
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
09/22/2025
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
03/14/2024
C71T
CANCELLED SECTION 71
07/14/2023
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
01/03/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/12/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/12/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
07/12/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/12/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/12/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/12/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/25/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/25/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/06/2018
NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/31/2017
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/22/2017
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/05/2017
FIMP
FINAL DISPOSITION PROCESSED
04/05/2017
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/03/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/02/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
01/03/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/22/2016
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
11/25/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/18/2016
PUBO
PUBLISHED FOR OPPOSITION
10/18/2016
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/28/2016
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
09/28/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/28/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/12/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/31/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/16/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/16/2016
ALIE
ASSIGNED TO LIE
08/14/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/08/2016
RFNT
REFUSAL PROCESSED BY IB
02/27/2016
MAFR
APPLICATION FILING RECEIPT MAILED
02/09/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/08/2016
RFRR
REFUSAL PROCESSED BY MPU
02/08/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/05/2016
CNRT
NON-FINAL ACTION WRITTEN
02/04/2016
DOCK
ASSIGNED TO EXAMINER
02/03/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/03/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/30/2016
Continuous trademark protection
Get notified about every new filing that threatens CONTERA PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.